[go: up one dir, main page]

MX2016009387A - Una composicion que puede rociarse que contiene oxido de zinc y un propelente de fluoro olefina. - Google Patents

Una composicion que puede rociarse que contiene oxido de zinc y un propelente de fluoro olefina.

Info

Publication number
MX2016009387A
MX2016009387A MX2016009387A MX2016009387A MX2016009387A MX 2016009387 A MX2016009387 A MX 2016009387A MX 2016009387 A MX2016009387 A MX 2016009387A MX 2016009387 A MX2016009387 A MX 2016009387A MX 2016009387 A MX2016009387 A MX 2016009387A
Authority
MX
Mexico
Prior art keywords
zinc oxide
sprayed
composition
propellent
olefine
Prior art date
Application number
MX2016009387A
Other languages
English (en)
Other versions
MX380671B (es
Inventor
Dann Thomas
Nelson Renee
Wagner Brian
Walter Mary
Original Assignee
Mission Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mission Pharma Co filed Critical Mission Pharma Co
Publication of MX2016009387A publication Critical patent/MX2016009387A/es
Publication of MX380671B publication Critical patent/MX380671B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

Se proporciona una composición de óxido de zinc que puede rociarse. La composición de óxido de zinc que puede rociarse puede utilizarse en el tratamiento de diversos padecimientos cutáneos. La composición de óxido de zinc que puede rociarse incluye partículas de óxido de zinc y un propelente de fluoro olefina. Los presentes inventores han determinado que al seleccionar un propelente que tiene determinada gravedad específica, presión de vapor y peso molecular, y al controlar la viscosidad de los diversos componentes de la composición, la composición de óxido de zinc resultante resiste el asentamiento, de tal modo que se mantiene una distribución sustancialmente homogénea de las partículas de óxido de zinc y puede rociarse en forma uniforme sobre una superficie sin que se corra una vez que se aplique.
MX2016009387A 2014-02-14 2015-02-11 Una composicion que puede rociarse que contiene oxido de zinc y un propelente de fluoro olefina. MX380671B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461939826P 2014-02-14 2014-02-14
PCT/US2015/015315 WO2015123237A1 (en) 2014-02-14 2015-02-11 Sprayable composition containing zinc oxide and a fluoro-olefin propellant

Publications (2)

Publication Number Publication Date
MX2016009387A true MX2016009387A (es) 2016-12-08
MX380671B MX380671B (es) 2025-03-12

Family

ID=53797100

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009387A MX380671B (es) 2014-02-14 2015-02-11 Una composicion que puede rociarse que contiene oxido de zinc y un propelente de fluoro olefina.

Country Status (10)

Country Link
US (1) US11007151B2 (es)
EP (1) EP3104842B1 (es)
JP (1) JP6626450B2 (es)
KR (1) KR102302063B1 (es)
CN (1) CN106029056B (es)
AU (1) AU2015217274B2 (es)
CA (1) CA2936430C (es)
ES (1) ES2894679T3 (es)
MX (1) MX380671B (es)
WO (1) WO2015123237A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381156B2 (en) * 2014-02-14 2016-07-05 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
CA2936409C (en) 2014-02-14 2023-03-14 Mission Pharmacal Company Spray delivery device
ITUB20155223A1 (it) * 2015-10-22 2017-04-22 Icf Srl Composizione spruzzabile secca e suo uso topico esterno in applicazioni veterinarie

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3770648A (en) 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
NZ183230A (en) 1976-02-24 1978-11-13 Johnson & Johnson Deodorant aerosol composition in association with a container
US4981677A (en) 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
FR2668927B1 (fr) 1990-11-09 1993-01-08 Oreal Composition cosmetique anhydre sous forme aerosol pour la formation d'une mousse.
US5143288A (en) 1991-02-14 1992-09-01 S. C. Johnson & Son, Inc. Compressed gas aerosol spray system with a dip tube vapor tap hole
JPH0692382A (ja) 1991-08-27 1994-04-05 Pacific Ind Ltd 清浄空気を推進剤として用いたエアゾールスプレー、及び、その製造方法
CA2180332C (en) * 1994-11-03 2006-01-10 Peter J. Lentini Sprayable compositions containing dispersed powders and methods for using the same
CA2210160A1 (en) 1995-01-18 1996-07-25 Roger Jeffcoat Cosmetics containing thermally-inhibited starches
US7234795B2 (en) * 1997-07-15 2007-06-26 Silverbrook Research Pty Ltd Inkjet nozzle with CMOS compatible actuator voltage
US5968494A (en) 1998-02-24 1999-10-19 National Starch And Chemical Investment Holding Corporation Polyurethanes with carboxylate functionality for hair fixative applications
US6047946A (en) 1998-02-27 2000-04-11 Precision Valve Corporation Blocking structure for preventing actuation of a valve for pressurized containers
US6345775B1 (en) 1998-07-30 2002-02-12 Wilsoart International, Inc. Very high solid content aerosol delivery system
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6165450A (en) 1999-05-03 2000-12-26 Em Industries, Inc. Sprayable sunscreen compositions
US6627178B1 (en) 1999-07-30 2003-09-30 Garret D. Cawthon Methods, compositions and systems for the prevention and treatment of diaper rash
US20060034937A1 (en) 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DK1286652T3 (da) 2000-05-08 2007-01-08 Pfizer Prod Inc Hudbeskyttende spray-præparater
US6394321B1 (en) 2001-12-20 2002-05-28 Precision Valve Corporation Aerosol powder valve
EP1369113B1 (en) 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US7597880B2 (en) 2003-02-24 2009-10-06 L'oreal Multimineral no-mix relaxer
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005115336A2 (en) 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
JP2008539255A (ja) 2005-04-26 2008-11-13 マイクロビア インコーポレーテッド 高コレステロール血症のための４−ビアリーリル−１−フェニルアゼチジン−２−オングルクロニド誘導体
BRPI0612448A2 (pt) 2005-05-09 2010-11-23 Foamix Ltd composição espumosa de sacarìdeo
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US7884136B2 (en) 2005-06-27 2011-02-08 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US8465728B2 (en) 2005-06-28 2013-06-18 S.C. Johnson & Son, Inc. Composition and aerosol spray dispenser for eliminating odors in air
CA2613771C (en) 2005-06-28 2011-01-18 S. C. Johnson & Son, Inc. A composition and its physical requirements for eliminating odors in air
US20110150792A1 (en) 2008-12-10 2011-06-23 Yun Shao Zinc oxide aqueous and non-aqueous dispersions
JP4358197B2 (ja) 2006-03-17 2009-11-04 アース製薬株式会社 全量噴射エアゾール装置
TW200806342A (en) 2006-06-28 2008-02-01 S C Johnson & Amp Son Inc Composition and aerosol spray dispenser for eliminating odors in air
US9345649B2 (en) 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels
KR100820074B1 (ko) * 2006-12-22 2008-04-11 (주)아모레퍼시픽 알킬폴리자일록사이드계 유화제를 함유하여 고함량의내상을 안정화시킨 유중수형 화장료 조성물
JP5946990B2 (ja) 2007-08-29 2016-07-06 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 化粧品及び医薬品使用のための精油を含有する糖系界面活性剤マイクロエマルジョン
CN101821372B (zh) 2007-09-05 2012-07-18 巴斯夫欧洲公司 含有染料-聚合物络合物的家庭和织物护理组合物
EP2219975B1 (en) 2007-10-31 2014-07-09 Plasticum Netherlands B.V. Spray cap
WO2009128933A1 (en) 2008-04-15 2009-10-22 Sarcode Corporation Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
US8087548B2 (en) 2008-05-14 2012-01-03 S.C. Johnson & Son, Inc. Spray products with particles and improved valve for inverted dispensing without clogging
NL2004437C2 (en) 2010-03-19 2011-09-20 Forte Iq B V Spray-pumpable comprising composition suitable for topical skin application.
WO2011155630A1 (ja) 2010-06-11 2011-12-15 株式会社ダイゾー エアゾール組成物
JP5841732B2 (ja) 2011-03-22 2016-01-13 株式会社ダイゾー エアゾール組成物
JP5786859B2 (ja) 2010-07-28 2015-09-30 東亞合成株式会社 重合体微粒子及びこれを含む皮膚外用組成物
WO2012027742A2 (en) 2010-08-27 2012-03-01 Fibrocell Technologies, Inc. Topical dermal formulations
US20120058973A1 (en) 2010-09-02 2012-03-08 Saroja Narasimhan Compositions comprising a silicone water-in-oil emulsifier and a low nitrogen containing amino-functional silicone gum
JP5937007B2 (ja) * 2010-09-10 2016-06-22 株式会社ダイゾー 発泡性エアゾール組成物
TWI430527B (zh) * 2011-07-13 2014-03-11 Univ Nat Cheng Kung Ｑ－切換引發之增益切換鉺脈衝雷射系統
EP2773324A4 (en) * 2011-11-03 2015-07-01 Prec Dermatology Inc STABLE DERMATOLOGICAL AEROSOL FOAMS USING REACTIVE PROPELLERS
NL2008443C2 (en) 2012-03-09 2013-09-16 Dreumex B V Aerosol container comprising a dermatological compostion and a foaming agent.
MX2014011181A (es) 2012-03-22 2015-03-06 Prec Dermatology Inc Microemulsiones basadas en ciclodextrina y usos dermatologicos de las mismas.
EP2961385A4 (en) * 2013-02-28 2016-07-27 Prec Dermatology Inc TOPICAL FORMULATIONS OF CORTICOSTEROIDS WITH INCREASED BIOAVAILABILITY
CA2936409C (en) 2014-02-14 2023-03-14 Mission Pharmacal Company Spray delivery device
US9381156B2 (en) 2014-02-14 2016-07-05 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles

Also Published As

Publication number Publication date
CA2936430A1 (en) 2015-08-20
US20150231071A1 (en) 2015-08-20
JP2017505802A (ja) 2017-02-23
CA2936430C (en) 2022-05-31
EP3104842B1 (en) 2021-10-06
CN106029056A (zh) 2016-10-12
ES2894679T3 (es) 2022-02-15
KR102302063B1 (ko) 2021-09-13
MX380671B (es) 2025-03-12
CN106029056B (zh) 2020-04-10
US11007151B2 (en) 2021-05-18
EP3104842A1 (en) 2016-12-21
EP3104842A4 (en) 2017-09-27
JP6626450B2 (ja) 2019-12-25
AU2015217274A1 (en) 2016-07-14
AU2015217274B2 (en) 2019-07-25
KR20160114617A (ko) 2016-10-05
WO2015123237A1 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
CL2018001790A1 (es) Procesos para preparar un inhibidor de jak1 y nuevas formas de este (divisional solicitud 201602748)
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
MX2016012530A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y metodos de uso.
CL2016002971A1 (es) Combinación.
CO2017005995A2 (es) Composiciones para el cuidado bucal y métodos de uso
MX2020010841A (es) Composicion detergente.
MX2017006149A (es) Composiciones para el cuidado personal con dos fases beneficas.
CR20180069A (es) Derivados de la sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b
CL2015003135A1 (es) Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimorficas y métodos de uso.
CL2017002031A1 (es) Formulación en polvo nasal para el tratamiento de hipoglicemia
MX2018005165A (es) Métodos para el tratamiento de padecimientos asociados con la activacion del complemento dependiente de masp-2.
AR100089A1 (es) Fluido de tratamiento
MX2018009536A (es) Composiciones para el cuidado bucal y metodos para utilizar las composiciones.
TWD173705S (zh) 無氣式泵
CR20170005A (es) Derivados de insoindolina
TWD173704S (zh) 無氣式泵
EP3333223A4 (en) COMPOSITION, COATING FILM, FLUOROUS COATING FILM AND LAMINATE
ES2732368T3 (es) Bacteriófago novedoso y composición que lo contiene
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
MX2016015569A (es) Metodos y composiciones para inmunomodulacion.
MX389135B (es) Composicion de polipropileno adecuada para pintar sin aprestador.
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
MX2016009387A (es) Una composicion que puede rociarse que contiene oxido de zinc y un propelente de fluoro olefina.
ECSP17024579A (es) Método de tratamiento para antibrote de tubérculos con cantidad reducida de cipc
MX2017000031A (es) Composicion de revestimiento estable.